Could improving sleep boost a soldier’s recovery from post-traumatic stress disorder?
New York drug maker Tonix Pharma seems to think so; it’s testing a long-approved muscle relaxant, cyclopenzaprine, as a way to help calm the brain before sleep to subdue PTSD symptoms. The company just got breakthrough designation from the Food and Drug Administration, and will be entering Phase 3 trials in patients with military-related PTSD in the first quarter of 2017.
We spoke with Tonix CEO Dr. Seth Lederman:
About the Author Reprints
The approval of cyclobenzaprine as a “breakthrough” simply shows how far we have to go in developing more meaningful pharmacologic treatments for PTSD.
So true 🙂
Wonder what it will cost, considering cyclobenzaprine (Flexiril) costs about 11 cents a pill. Any studies showing the sublingual form is any better? PS: Amitriptyline and nortriptylline have similar chemical structures.